These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23837248)

  • 1. Treatment of submacular haemorrhage in patients with neovascular age related macular degeneration.
    Lumi X; Sulak M
    Coll Antropol; 2013 Apr; 37 Suppl 1():223-6. PubMed ID: 23837248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degeneration.
    Fang IM; Lin YC; Yang CH; Yang CM; Chen MS
    Eye (Lond); 2009 Feb; 23(2):397-406. PubMed ID: 17975562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
    Chang W; Garg SJ; Maturi R; Hsu J; Sivalingam A; Gupta SA; Regillo CD; Ho AC
    Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of intravitreal tissue plasminogen activator and expansile gas injection for submacular haemorrhage in Thais.
    Ratanasukon M; Kittantong A
    Eye (Lond); 2005 Dec; 19(12):1328-32. PubMed ID: 15565185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage.
    Treumer F; Roider J; Hillenkamp J
    Br J Ophthalmol; 2012 May; 96(5):708-13. PubMed ID: 22174095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravitreal injection of rt-PA and gas in the management of minor submacular haemorrhages secondary to age-related macular degeneration].
    Hattenbach LO; Brieden M; Koch F; Gümbel H
    Klin Monbl Augenheilkd; 2002 Jul; 219(7):512-8. PubMed ID: 12195317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumatic displacement of a dense submacular hemorrhage with or without tissue plasminogen activator.
    Yang PM; Kuo HK; Kao ML; Chen YJ; Tsai HH
    Chang Gung Med J; 2005 Dec; 28(12):852-9. PubMed ID: 16515019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration.
    Olivier S; Chow DR; Packo KH; MacCumber MW; Awh CC
    Ophthalmology; 2004 Jun; 111(6):1201-8. PubMed ID: 15177972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage.
    Treumer F; Klatt C; Roider J; Hillenkamp J
    Br J Ophthalmol; 2010 Jan; 94(1):48-53. PubMed ID: 19946027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.
    Hassan AS; Johnson MW; Schneiderman TE; Regillo CD; Tornambe PE; Poliner LS; Blodi BA; Elner SG
    Ophthalmology; 1999 Oct; 106(10):1900-6; discussion 1906-7. PubMed ID: 10519583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.
    Kung YH; Wu TT; Hong MC; Sheu SJ
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):469-74. PubMed ID: 20925578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement.
    Thompson JT; Sjaarda RN
    Trans Am Ophthalmol Soc; 2005; 103():98-107; discussion 107. PubMed ID: 17057793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study.
    Meyer CH; Scholl HP; Eter N; Helb HM; Holz FG
    Acta Ophthalmol; 2008 Aug; 86(5):490-4. PubMed ID: 18221499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab in the treatment of neovascular age-related macular degeneration, 6- and 9-month results.
    Cleary CA; Jungkim S; Ravikumar K; Kelliher C; Acheson RW; Hickey-Dwyer M
    Eye (Lond); 2008 Jan; 22(1):82-6. PubMed ID: 17891059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreous injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degeneration.
    Guthoff R; Guthoff T; Meigen T; Goebel W
    Retina; 2011 Jan; 31(1):36-40. PubMed ID: 20921929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement.
    Handwerger BA; Blodi BA; Chandra SR; Olsen TW; Stevens TS
    Arch Ophthalmol; 2001 Jan; 119(1):28-32. PubMed ID: 11146723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas.
    Chen CY; Hooper C; Chiu D; Chamberlain M; Karia N; Heriot WJ
    Retina; 2007 Mar; 27(3):321-8. PubMed ID: 17460587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage.
    Stifter E; Michels S; Prager F; Georgopoulos M; Polak K; Hirn C; Schmidt-Erfurth U
    Am J Ophthalmol; 2007 Dec; 144(6):886-892. PubMed ID: 17916314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age-related macular degeneration].
    Auriol S; Mahieu L; Lequeux L; Quintyn JC; Pagot-Mathis V
    J Fr Ophtalmol; 2010 Feb; 33(2):84-91. PubMed ID: 20092910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration.
    Sacu S; Stifter E; Vécsei-Marlovits PV; Michels S; Schütze C; Prünte C; Schmidt-Erfurth U
    Eye (Lond); 2009 Jun; 23(6):1404-10. PubMed ID: 18756282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.